Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer’s disease
Preprint
Abstract
Alzheimer’s disease (AD) is one of the most common causes of dementia and frailty. This study aimed to use bioinformatics analysis to identify differentially expressed genes (DEGs) in AD. The Expression profiling by high throughput sequencing dataset GSE125583 was downloaded from the Gene Expression Omnibus (GEO) database and DEGs were identified. After assessment of Gene Ontology (GO) terms and pathway enrichment for DEGs, a protein–protein interaction (PPI) network, module analysis, miRNA-hub gene regulatory network construction and TF-hub gene regulatory network were conducted via comprehensive target prediction and network analyses. Finally, we validated hub genes by receiver operating characteristic curve (ROC). In total, 956 DEGs were identified in the AD samples, including 479 up regulated genes and 477 down regulated genes. Functional enrichment analysis showed that these DEGs are mainly involved in the neuronal system, GPCR ligand binding, regulation of biological quality and cell communication. The hub genes of PAK1, ELAVL2, NSF, HTR2C, TERT, UBD, MKI67, HSPB1, PYHIN1 and TES might be associated with AD. The diagnostic value and expression levels of these hub genes in AD were further confirmed by ROC analysis. In conclusion, we identified pathways and crucial candidate genes that affect the outcomes of patients with AD, and these genes might serve as potential therapeutic targets.Keywords
This publication has 187 references indexed in Scilit:
- Identification of COL6A2 mutations in progressive myoclonus epilepsy syndromeHuman Genetics, 2012
- Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's diseaseProgress in Neurobiology, 2012
- CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: Relevance to Alzheimer’s diseaseBiochemical and Biophysical Research Communications, 2011
- Fine mapping of Xq11.1‐q21.33 and mutation screening of RPS6KA6, ZNF711, ACSL4, DLG3, and IL1RAPL2 for autism spectrum disorders (ASD)Autism Research, 2011
- Disruption of Sodium Bicarbonate Transporter SLC4A10 in a Patient With Complex Partial Epilepsy and Mental RetardationArchives of Neurology, 2008
- g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experimentsNucleic Acids Research, 2007
- Prediction of psychosis onset in Alzheimer disease: The role of depression symptom severity and the HTR2A T102C polymorphismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotypeProceedings of the National Academy of Sciences, 2007
- Low mRNA levels of RGS4 splice variants in Alzheimer's disease: Association between a rare haplotype and decreased mRNA expressionSynapse, 2005
- Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's diseaseJournal of Peptide Science, 2004